Concepedia

Yuki Sato

YS

Statistics

Publications

7

Citations

516

H-Index

7

Active since

2014

Affiliations

Yamaguchi University(Current)

Nagoya City University

Eisai (Japan)

Eisai (United States)

Yuki Sato is an author at Yamaguchi University specializing in molecular oncology, cancer cell signaling, and oncology.

ORCID

Publications per year

2014–2024

7

Publications

7

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states

Takeshi Yoshida, Yoichi Ozawa, Takayuki Kimura et al. · British Journal of Cancer · 2014 · 357 citations · Full text

, , +17

A landmark in drug discovery based on complex natural product synthesis

Satoshi Kawano, Ken Ito, Kenzo Yahata et al. · Scientific Reports · 2019 · 39 citations · Full text

, , +10

FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells

Keisuke Maeda, Makoto Habara, Mitsuyasu Kawaguchi et al. · Molecular Oncology · 2021 · 35 citations · Full text

, , +16

Calcineurin regulates the stability and activity of estrogen receptor α

Takahiro Masaki, Makoto Habara, Yuki Sato et al. · Proceedings of the National Academy of Sciences · 2021 · 28 citations · Full text

, , +17

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer

Makoto Habara, Yuki Sato, Takahiro Goshima et al. · Proceedings of the National Academy of Sciences · 2022 · 26 citations · Full text

, , +16

1–5 of 7